Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Neurology Devices Market size was valued at USD 15.51 billion in 2024 and is likely to cross USD 41.68 billion by 2037, registering more than 7.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of neurology devices is estimated at USD 16.55 billion.
The growth of the market can be attributed to the increasing prevalence of neurological diseases, such as, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, epilepsy, and other disorders. According to the data by the World Health Organization (WHO), 47.5 million people suffer with dementia globally, with 7.7 million new cases every year. The increasing prevalence of neurological disorders is estimated to promote the demand for neurology devices. Moreover, increasing global health expenditure is further anticipated to fuel the market growth. According to the data by the World Bank, USD 1,110.268 was spent on per capita healthcare, in 2018.
Moreover, the increasing geriatric population is projected to fuel the market growth, as older people are more vulnerable towards neurological diseases. According to the other World Bank report, 723,184,486 people were above the age of 65 years, in 2020, globally.
Neurology Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Prevalence of Neurological Disorders
- Growing Geriatric Population Globally
Challenges
- Implementation of Stringent Government Regulations for Approval of Neurology Devices
- Lack of Health Awareness in Underdeveloped Regions
Neurology Devices Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
7.9% |
Base Year Market Size (2024) |
USD 15.51 billion |
Forecast Year Market Size (2037) |
USD 41.68 billion |
Regional Scope |
|
Neurology Devices Segmentation
The market is segmented by device into cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device, and others, out of which, the cerebrospinal fluid management device segment is anticipated to hold the notable share in the global market over the forecast period. This can be accredited to the use of these devices for diagnosis and treatment of multiple sclerosis, myelitis, and encephalitis.
Our in-depth analysis of the global market includes the following segments:
By Device |
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportNeurology Devices Industry - Regional Synopsis
On the basis of geographical analysis, the global neurology devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Asia Pacific industry is poised to account for largest revenue share by 2037, led by increasing awareness regarding healthcare amongst people, along with improving healthcare facilities in the region.
The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the higher healthcare expenditure in the region, and presence of patient-friendly reimbursement policies. According to the World Bank, 16.885% of the GDP of United States was spent for healthcare in 2018.

Companies Dominating the Neurology Devices Landscape
- Eli Lilly and Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson
- LivaNova PLC
- Medtronic Plc
- Abbot Laboratories
- Magstim Co Ltd.
- Pear Therapeutics, Inc.
- Penumbra, Inc.
- Stryker Corporation
- Boston Scientific Corporation
In the News
- February, 2021: Koninklijke Philips N.V. announced the acquisition of BioTelemetry, Inc., a leading provider of remote diagnostics and monitoring.
- October, 2020: Stryker B.V., leading medical technology company, announced the complete acquisition of Wright Medical Group N.V.
Author Credits: Radhika Pawar
- Report ID: 3853
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT